Radiation Therapy Section, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Hiroshima, 734-8551, Japan.
Department of Radiation Oncology, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Hiroshima, 734-8551, Japan.
Med Phys. 2021 Jun;48(6):3200-3207. doi: 10.1002/mp.14871. Epub 2021 Apr 24.
To develop a dosimetric internal target volume (ITV) margin (DIM) for respiratory motion in lung stereotactic body radiotherapy (SBRT) and to evaluate DIM with a nonuniform volume prescription (NVP) and the point prescription (PP).
Volumetric modulated arc therapy (VMAT) treatment plans with PP and NVP were created on a heterogeneous programmable respiratory motion phantom, with a tumor (30-mm diameter) inside a cylindrical lung insert. The tumor was defined as the gross tumor volume (GTV), equal to the clinical target volume (CTV). Five-millimeter and 0-mm margins were used for the ITV and setup margins, respectively. The phantom was moved in cranio-caudal direction with a biquadratic sinusoidal waveform with a 4-s cycle and an amplitude of ±5-10 mm. The interplay effect was evaluated by measuring the dose profile with a film in the sagittal plane for different respiratory periods and different initial respiratory phases. DIM was based on the respiratory motion amplitude that satisfied 100% and 95% coverage of the prescribed dose by the minimum dose of the CTV. Moreover, the absolute dose was measured with and without respiratory motion for NVP by a pinpoint chamber.
The dose difference in the tumor region due to the interplay effect was within 1.0%. The gamma passing rate was over 95.1% for different respiratory periods and 98.6% for different initial respiratory phases. DIM with PP was almost equivalent to the margin of the respiratory motion. However, DIM with NVP was 2.0 and 1.8 times larger than the margin of the respiratory motion for the 100% and 95% coverage of the prescribed doses, respectively.
The interplay effects experienced between the MLC sequence and tumor motion were negligible for NVP. The DIM analysis revealed that the margin to compensate the respiratory tumor motion could be reduced by more than 44-50% for NVP in SBRT.
为肺立体定向体部放射治疗(SBRT)中的呼吸运动开发剂量学内靶区(ITV)边界(DIM),并使用非均匀体积处方(NVP)和点处方(PP)评估 DIM。
在具有肿瘤(30 毫米直径)的异质可编程呼吸运动体模上创建具有 PP 和 NVP 的容积调制弧形治疗(VMAT)治疗计划,肿瘤位于圆柱形肺插件内。肿瘤被定义为大体肿瘤体积(GTV),等于临床靶区(CTV)。ITV 和设置边界分别使用 5 毫米和 0 毫米边界。体模沿头足方向以 4 秒周期和 ±5-10 毫米的幅度的双二次正弦波运动。通过在矢状面用胶片测量不同呼吸周期和不同初始呼吸相位的剂量分布来评估相互作用效应。DIM 基于满足 100%和 95%处方剂量覆盖的最小 CTV 剂量的呼吸运动幅度。此外,通过 pinpoint 室在没有呼吸运动的情况下测量 NVP 的绝对剂量。
由于相互作用效应,肿瘤区域的剂量差异在 1.0%以内。不同呼吸周期的伽马通过率超过 95.1%,不同初始呼吸相位的伽马通过率超过 98.6%。PP 下的 DIM 几乎等同于呼吸运动的边界。然而,对于 100%和 95%的处方剂量覆盖,NVP 下的 DIM 分别比呼吸运动边界大 2.0 和 1.8 倍。
对于 NVP,MLC 序列和肿瘤运动之间经历的相互作用效应可以忽略不计。DIM 分析表明,对于 SBRT 中的 NVP,可以将补偿呼吸肿瘤运动的边界减少 44-50%以上。